43 reports

Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intel

151 pages • By Allied Market Research

Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intelligence, Growth Trends, Size, Share, Opportunities and Forecast, 2013 - 2020Biomarkers...

3 612 4 515 2 890
Dec 2013

Global Imaging Biomarkers Market 2014-2018

49 pages • By Infiniti Research Limited

TechNavio's analysts forecast the Global Imaging Biomarkers market to grow at a CAGR of 15.09 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Imaging Biomarkers market has also been witnessing the emergence of personalized medicines. However, the...

1 600 2 000 1 280
Nov 2013

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

350 pages • By Industry Experts

The potential offered by biomarkers in shaping the outcomes of clinical trials, identifying new drug targets and developing diagnostic assays for detecting diseases early is immense, which has ensued in a large number of scientific publications coming out over the past two decades. Biomarker research encompasses widespread fields of discipline,...

3 600 4 500 2 880
Nov 2013

Molecular Diagnostics in Cancer Testing

232 pages • By TriMark Publications

Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics,...

2 720 3 400 2 176
Nov 2013

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 201

327 pages • By MarketsandMarkets

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 2018) A biomarker is an identifiable and measurable characteristic, which...

3 720 4 650 2 976
Sep 2013

Companion Biomarkers in Drug Development

356 pages • By TriMark Publications

Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic. This linkage can be an important component of the drug development process; alternatively, the companion biomarker can be useful in ameliorating the regulatory process for the drug, or acting as an aid...

2 720 3 400 2 176
Aug 2013

Biomarkers: Technological and Commercial Outlook 2013-2023

178 pages • By Visiongain

Report DetailsBiomarkers - how to find R&D trends and potential salesWhat's the outlook for biomarkers? Visiongain's updated report predicts revenues to 2023. There you find the best places for sales growth, also understanding trends and opportunities.That study gives you revenue forecasts to 2023 at overall...

2 141 2 633 1 691
Jul 2013

Molecular Biomarkers for Cancer Detection and Management

By CHI Insight Pharma Reports

New to Insight Pharma Reports is Molecular Biomarkers for Cancer Detection and Management: Technologies, Markets, and Trends. This report focuses on recent progress and new directions in this highly dynamic diagnostic field. Covering extensive background and history, commercialization, and marketing trends of cancer biomarker technologies,...

1 996 2 495 1 597
Jul 2013

PharmaFocus: Biomarkers in Alzheimer’s Disease

179 pages • By Global Data

PharmaFocus: Biomarkers in Alzheimer’s Disease SummaryAlzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. The disease has emerged as a major global health priority especially because of its rapidly accelerating...

3 196 3 995 2 557
Jun 2013

Personalized Medicine Market Analysis

90 pages • By RNCOS

Advancements in the field of genomics have created ample opportunities for personalized medicines to emerge in the healthcare industry. Personalized medicine represents an interface of therapeutics and diagnostics. It involves the tailoring of treatments as per individuals. The growing research applications and identification of molecular...

960 1 200 768
May 2013

Cancer Diagnostic Testing World Markets

336 pages • By TriMark Publications

Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs of the disease are $126 billion annually. Pharmaceutical companies are developing more than...

2 720 3 400 2 176
May 2013

Advances in Disease Theranostics (Technical Insights)

By Frost & Sullivan

This research service analyses the latest developments that has occurred in the field of theranostics, both from a technology and industry perspective.

4 792 5 990 3 834
May 2013

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

153 pages • By BCC Research

REPORT SCOPEINTRODUCTIONBiomarkers are measurable and quantifiable biological indicators that can be used to diagnose or predict disease, monitor disease progression, indicate what treatment options may be most effective in an individual patient’s case and predict treatment response. They play a role both in...

5 320 6 650 4 256
Mar 2013